# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-053030
Filing Date
2025-04-11
Accepted
2025-04-11 07:45:36
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | lrmr_ars_02apr2024.pdf | ARS | 1560133
| Complete submission text file | 0000950170-25-053030.txt |  | 2150166

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36510 | Film No.: 25829877
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)